Drugs / autologous adipose tissue derived stromal vascular fraction (SVF)
autologous adipose tissue derived stromal vascular fraction (SVF)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04340284 | Nov 2019 → Feb 2020 | — | Dr. Himanshu Bansal Foundation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous adipose tissue derived stromal vascular fraction (SVF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04340284 ↗ |
| Modality | Cell therapy | “freshly isolated autologous adipose stem cell preparations (the stromal vascular fraction [SVF] of adipose tissue)” PMID 27388241 ↗ Jul 2016 |
| Route | Other | “fluoroscopic guided percutaneous injection of SVF at the site of fracture” NCT04340284 ↗ |